Drug-resistant tuberculosis in the WHO European Region: An analysis of surveillance data

Drug Resistance Updates

Volumn 16, Issue 6, 2013, Pages 108-115

  Zignol, Matteo ^a   Dara, Masoud ^a   Dean, Anna S ^a   Falzon, Dennis ^a   Dadu, Andrei ^a   Kremer, Kristin ^a   Hoffmann, Harald ^b   Hoffner, Sven ^c,d   Floyd, Katherine ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Drug resistance; European Region; MDR TB; Surveillance; Tuberculosis

Indexed keywords

AMIKACIN; CAPREOMYCIN; ISONIAZID; KANAMYCIN; QUINOLONE DERIVATIVE; RIFAMPICIN; TERBIUM; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; DISEASE SURVEILLANCE; ESTONIA; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GERMANY; HEALTH SURVEY; HUMAN; LATVIA; LUNG TUBERCULOSIS; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RUSSIAN FEDERATION; SWEDEN; TREND STUDY; UNITED KINGDOM; WORLD HEALTH ORGANIZATION; EPIDEMIOLOGY; EUROPE; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; MICROBIAL SENSITIVITY TEST; TIME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; EUROPE; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; RIFAMPIN; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION;

EID: 84900818456     PISSN: 13687646     EISSN: 15322084     Source Type: Journal    
DOI: 10.1016/j.drup.2014.02.003     Document Type: Review

References (32)

1. I. Abubakar, M. Zignol, D. Falzon, M. Raviglione, L. Ditiu, S. Masham, I. Adetifa, N. Ford, H. Cox, S.D. Lawn, B.J. Marais, T.D. McHugh, P. Mwaba, M. Bates, M. Lipman, L. Zijenah, S. Logan, R. McNerney, A. Zumla, K. Sarda, P. Nahid, M. Hoelscher, M. Pletschette, Z.A. Memish, P. Kim, R. Hafner, S. Cole, G.B. Migliori, M. Maeurer, M. Schito, and A. Zumla Drug-resistant tuberculosis: time for visionary political leadership Lancet Infect. Dis. 13 2013 529 539
2. M.A. Aziz, A. Wright, A. Laszlo, A. De Muynck, F. Portaels, A. Van Deun, C. Wells, P. Nunn, L. Blanc, and M. Raviglione WHO/International union against tuberculosis and lung disease global project on anti-tuberculosis drug resistance surveillance, epidemiology of antituberculosis drug resistance (the global project on anti-tuberculosis drug resistance surveillance): an updated analysis Lancet 368 2006 2142 2154
3. M. Dara, P. de Colombani, R. Petrova-Benedict, R. Centis, J.P. Zellweger, A. Sandgren, E. Heldal, G. Sotgiu, N. Jansen, R. Bahtijarevic, G.B. Migliori Wolfheze Transborder Migration Task Force Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement Eur. Respir. J. 40 2012 1081 1090
4. I. Devaux, D. Manissero, K. Fernandez de la Hoz, K. Kremer, D. van Soolingen EuroTB network Surveillance of extensively drug-resistant tuberculosis in EUROPE, 2003-2007 Euro Surveill. vol. 15 2010 (pii:19518)
5. R. Diel, J. Vandeputte, G. de Vries, J. Stillo, M. Wanlin, and A. Nienhaus Costs of tuberculosis disease in the EU - a systematic analysis and cost calculation Eur. Respir. J. 43 2014 554 565
6. M.A. Espinal, A. Laszlo, L. Simonsen, F. Boulahbal, S.J. Kim, A. Reniero, S. Hoffner, H.L. Rieder, N. Binkin, C. Dye, R. Williams, and M.C. Raviglione Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance N. Engl. J. Med. 344 2001 1294 1303
7. D. Falzon, E. Jaramillo, H. Schünemann, M. Arentz, J. Bayona, L. Blanc, C. Daley, C. Duncombe, C. Fitzpatrick, A. Gebhard, H. Getahun, M. Henkens, T. Holtz, J. Keravec, S. Keshavjee, A. Khan, R. Kulier, V. Leimane, C. Lienhardt, A. Mariandyshev, G.B. Migliori, F. Mirzayev, C. Mitnick, P. Nunn, G. Nwagboniwe, O. Oxlade, D. Palmero, P. Pavlinac, M. Quelapio, M.C. Raviglione, M.L. Rich, S. Royce, S. RüschGerdes, A. Salakaia, R. Sarin, D. Sculier, F. Varaine, M. Vitoria, J.L. Walson, F. Wares, K. Weyer, R.A. White, and M. Zignol WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Eur. Respir. J. 38 2011 516 528
8. D. Falzon, E. Jaramillo, F. Wares, M. Zignol, K. Floyd, and M.C. Raviglione Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data Lancet Infect. Dis. 13 2013 690 697
9. H.E. Jenkins, V. Plesca, A. Ciobanu, V. Crudu, I. Galusca, V. Soltan, A. Serbulenco, M. Zignol, A. Dadu, M. Dara, and T. Cohen Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country Eur. Respir. J. 42 2013 1291 1301
10. T. Kompala, S.V. Shenoi, and G. Friedland Transmission of tuberculosis in resource-limited settings Curr. HIV/AIDS Rep. 10 2013 264 272
11. Medical Research Council Streptomycin treatment of pulmonary tuberculosis. A Medical Research Council investigation Br. Med. J. 2 1948 769 782
12. G.B. Migliori, J.P. Zellweger, I. Abubakar, E. Ibraim, J.A. Caminero, G. De Vries, L. D'Ambrosio, R. Centis, G. Sotgiu, O. Menegale, K. Kliiman, T. Aksamit, D.M. Cirillo, M. Danilovits, M. Dara, K. Dheda, A.T. Dinh-Xuan, H. Kluge, C. Lange, V. Leimane, R. Loddenkemper, L.P. Nicod, M.C. Raviglione, A. Spanevello, V.∅. Thomsen, M. Villar, M. Wanlin, J.A. Wedzicha, A. Zumla, F. Blasi, E. Huitric, A. Sandgren, and D. Manissero European union standards for tuberculosis care Eur. Respir. J. 39 2012 807 819
13. Ministry of Health of the Russian Federation Tuberculosis in the Russian Federation 2011: An Analytical Review of Statistical Indicators Used in the Russian Federation 2013 (in Russian)
14. A. Skrahina, H. Hurevich, A. Zalutskaya, E. Sahalchyk, A. Astrauko, S. Hoffner, V. Rusovich, A. Dadu, P. de Colombani, M. Dara, W. van Gemert, and M. Zignol Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors Bull. World Health Organ. 91 2013 36 45
15. A. Skrahina, H. Hurevich, A. Zalutskaya, E. Sahalchyk, A. Astrauko, W. van Gemert, S. Hoffner, V. Rusovich, and M. Zignol Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Eur. Respir. J. 39 2012 1425 1431
16. I.P. Stoicescu, D. Homorodean, D. Chiotan, O. Moldovan, D. Diculencu, C. Popa, A. Macri, I. Husar, L. Ditiu, M.A. Aziz, and S. Hoffner Romanian anti-TB drugs resistance surveillance 2003-2004 Pneumologia 57 2008 131 137
17. STOP TB Partnership Global Laboratory Initiative 2013 Retrieved 17 February, 2014 from http://www.stoptb.org/wg/gli/srln.asp
18. D.J. Ulmasova, G. Uzakova, M.N. Tillyashayhov, L. Turaev, W. van Gemert, H. Hoffmann, M. Zignol, K. Kremer, T. Gombogaram, J. Gadoev, P. du Cros, N. Muslimova, A. Jalolov, A. Dadu, P. de Colombani, O. Telnov, A. Slizkiy, B. Kholikulov, M. Dara, and D. Falzon Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010-2011 Euro Surveill. 18 2013 (pii:20609)
19. UN World Population Prospects: The 2012 Revision 2013 Retrieved 17 February, 2014 from http://esa.un.org/unpd/wpp/Excel-Data/population.htm
20. A. Van Deun, A. Wright, M. Zignol, K. Weyer, and H.L. Rieder Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories Int. J. Tuberc. Lung Dis. 15 2011 116 124
21. ®MTB/RIF Eur. Respir. J. 42 2013 252 271
22. WHO Guidelines for Surveillance of Drug Resistance in Tuberculosis (WHO/HTM/TB/2009.422) 4th ed. 2009 Retrieved 17 February, 2014 from http://whqlibdoc.who.int/publications/2009/9789241598675-eng.pdf
23. WHO WHO Policy on TB Infection Control in Health-Care Facilities, Congregate Settings and Households (WHO/HTM/TB/2009.419) 2009 Retrieved 17 February, 2014 from http://whqlibdoc.who.int/publications/2009/9789241598323- eng.pdf
24. World Health Organization Multidrug and Extensively Drug-Resistant TB (M/XDR-TB) - 2010 Global Report on Surveillance and Response (WHO/HTM/TB/2010.3) 2010 Retrieved 17 February, 2014 from http://whqlibdoc.who.int/publications/ 2010/9789241599191-eng.pdf
25. WHO Consolidated Action Plan to Prevent and Combat Multidrug- and Extensively Drug-Resistant Tuberculosis in the WHO European Region 2011-2015 (EUR/RC61/15) 2011 Retrieved 17 February, 2014 from http://www.euro.who.int/- data/assets/pdf-file/0007/147832/wd15E-TB-ActionPlan-111388.pdf
26. WHO Roadmap to Prevent and Combat Drug-Resistant Tuberculosis 2011 978 92 890 0246 2 Retrieved 17 February, 2014 from http://www.euro.who.int/-data/ assets/pdf-file/0011/148376/RC61-InfDoc3.pdf
27. WHO Global Tuberculosis Control (WHO/HTM/TB/2012.16) 2012 Retrieved 17 February, 2014 from http://www.who.int/tb/publications/global-report/en/index. html
28. WHO Global Tuberculosis Control (WHO/HTM/TB/2013.11) 2013 Retrieved 17 February, 2014 from http://www.who.int/iris/bitstream/10665/91355/1/ 9789241564656-eng.pdf
29. WHO The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis. Interim policy guidance (WHO/HTM/TB/2013.6) 2013 Retrieved 17 February, 2014 from http://apps.who.int/iris/bitstream/10665/84879/1/ 9789241505482-eng.pdf?ua=1
30. WHO The WHO Global TB Data Collection System 2013 Retrieved 17 February, 2014 from https://extranet.who.int/tme/
31. M. Zignol, W. van Gemert, D. Falzon, E. Jaramillo, L. Blanc, and M. Raviglione Modernizing surveillance of anti-tuberculosis drug resistance: from special surveys to routine testing Clin. Infect. Dis. 52 2011 901 906
32. M. Zignol, W. van Gemert, D. Falzon, C. Sismanidis, P. Glaziou, K. Floyd, and M. Raviglione Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007-2010 Bull World Health Organ. 90 2012 (111-9D)